Descrição

Reference drug (mesalazine and otilonium bromide) effects on colon macroscopic damage scores provide a benchmark for comparing the vegetal system's efficacy in the DNBS visceral pain model.

Figure 9

Chart

Source Paper

Researching New Therapeutic Approaches for Abdominal Visceral Pain Treatment: Preclinical Effects of an Assembled System of Molecules of Vegetal Origin.

Nutrients (2019)

PMID: 31861862

DOI: 10.3390/nu12010022

Cite This Figure

![Figure 9: Reference drug (mesalazine and otilonium bromide) effects on colon macroscopic damage scores provide a benchmark for comparing the vegetal system's efficacy in the DNBS visceral pain model.]()

> Source: Carmen Parisio et al. "Researching New Therapeutic Approaches for Abdominal Visceral Pain Treatment: Pr." *Nutrients*, 2019. PMID: [31861862](https://pubmed.ncbi.nlm.nih.gov/31861862/)

<figure>
  <img src="" alt="Reference drug (mesalazine and otilonium bromide) effects on colon macroscopic damage scores provide a benchmark for comparing the vegetal system's efficacy in the DNBS visceral pain model." />
  <figcaption>Figure 9. Reference drug (mesalazine and otilonium bromide) effects on colon macroscopic damage scores provide a benchmark for comparing the vegetal system's efficacy in the DNBS visceral pain model.<br>  Source: Carmen Parisio et al. "Researching New Therapeutic Approaches for Abdominal Visceral Pain Treatment: Pr." <em>Nutrients</em>, 2019. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31861862/">31861862</a></figcaption>
</figure>

Evidências Relacionadas

Aloe Vera (Inner Leaf Gel) para Irritable Bowel Syndrome (IBS)

Nota C · 3 estudos